The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
γδ T Cells Provide an Early Source of Interferon γ in Tumor Immunity
Open accessAbstract
Interferon (IFN)-γ is necessary for tumor immunity, however, its initial cellular source is unknown. Because γδ T cells primarily produce this cytokine upon activation, we hypothesized that they would provide an important early source of IFN-γ in tumor immunosurveillance. To address this hypothesis, we first demonstrated that γδ T cell–deficient mice had a significantly higher incidence of tumor development after challenge with a chemical carcinogen methylcholanthrene (MCA) or inoculation with the melanoma cell line B16. In wild-type mice, γδ T cells were recruited to the site of tumor as early as day 3 after inoculation, followed by αβ T cells at day 5. We then used bone marrow chimeras and fetal liver reconstitutions to create mice with an intact γδ T cell repertoire but one that was specifically deficient in the capacity to produce IFN-γ. Such mice had a higher incidence of tumor development, induced either with MCA or by inoculation of B16 melanoma cells, compared with mice with IFN-γ–competent γδ T cells. Moreover, genetic deficiency of γδ T cells resulted in impaired IFN-γ production by tumor antigen-triggered αβ T cell upon immunization with tumor lysate. These results demonstrate that γδ T cells can play a necessary role in tumor immunity through provision of an early source of IFN-γ that in turn may regulate the function of tumor-triggered αβ T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465 · cited 5×
“In addition, we observed a significantly higher percentage of tumors in the IFN-� � /� mice (Fig. 4 A, P � 0.01), consistent with previous findings that IFN-� is essential in tumor Immunosurveillance in the MCA-induced tumor model ( 3 ).”
BackgroundMethodResultInfluentialRecognition of Stress-Induced MHC Molecules by Intestinal Epithelial γδ T Cells
Groh, V., Steinle, A., Bauer, S., & Spies, T. (1998) · Science · doi:10.1126/science.279.5357.1737 · Cited by 1,142
γδ Cells: A Right Time and a Right Place for a Conserved Third Way of Protection
Hayday, A. C. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.975 · Cited by 1,136
An Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039
T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells
Afkarian, M., Sedy, J. R., Yang, J., Jacobson, N. G., Cereb, N., Yang, S. Y., Murphy, T. L., & Murphy, K. M. (2002) · Nature Immunology · doi:10.1038/ni794 · Cited by 1,037
Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Regulation of Cutaneous Malignancy by γδ T Cells
Girardi, M., Oppenheim, D. E., Steele, C. R., Lewis, J. M., Glusac, E., Filler, R., Hobby, P., Sutton, B., Tigelaar, R. E., & Hayday, A. C. (2001) · Science · doi:10.1126/science.1063916 · Cited by 1,004
Self-citationThe roles of IFNγ in protection against tumor development and cancer immunoediting
Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00038-7 · Cited by 899
Dighe, A. S., Richards, E., Old, L. J., & Schreiber, R. D. (1994) · Immunity · doi:10.1016/1074-7613(94)90087-6 · Cited by 663
Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis
Street, S. E. A., Cretney, E., & Smyth, M. J. (2001) · Blood · doi:10.1182/blood.v97.1.192 · Cited by 572
Different roles of αβ and γδ T cells in immunity against an intracellular bacterial pathogen
Mombaerts, P., Arnoldi, J., Russ, F., Tonegawa, S., & Kaufmann, S. H. E. (1993) · Nature · doi:10.1038/365053a0 · Cited by 406
Role of cytokines in determining T-lymphocyte function
O'Garra, A., & Murphy, K. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90128-7 · Cited by 393
Crowe, N. Y., Smyth, M. J., & Godfrey, D. I. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020092 · Cited by 352
Shires, J., Theodoridis, E., & Hayday, A. C. (2001) · Immunity · doi:10.1016/s1074-7613(01)00192-3 · Cited by 276
Zhang, Y., McCormick, L. L., Desai, S. R., Wu, C., & Gilliam, A. C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.3088 · Cited by 256
Tsuji, M., Mombaerts, P., Lefrancois, L., Nussenzweig, R. S., Zavala, F., & Tonegawa, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.345 · Cited by 211
Attributes of γδ intraepithelial lymphocytes as suggested by their transcriptional profile
Fahrer, A. M., Konigshofer, Y., Kerr, E. M., Ghandour, G., Mack, D. H., Davis, M. M., & Chien, Y.-H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171320798 · Cited by 168
Moore, T. A., Moore, B. B., Newstead, M. W., & Standiford, T. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2643 · Cited by 163
Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.
Maeurer, M. J., Martin, D., Walter, W., Liu, K., Zitvogel, L., Halusczcak, K., Rabinowich, H., Duquesnoy, R., Storkus, W. J., & Lotze, M. T. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.4.1681 · Cited by 155
Huber, S. A., Graveline, D., Newell, M. K., Born, W. K., & O’Brien, R. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4174 · Cited by 140
Natural killer T (NKT) cells and their role in antitumor immunity.
Brutkiewicz, R., & Sriram, V. (2002) · Critical reviews in oncology/hematology · doi:10.1016/s1040-8428(01)00198-6 · Cited by 118
Yin, Z., Chen, C.-H., Szabo, S. J., Glimcher, L. H., Ray, A., & Craft, J. E. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1566 · Cited by 107
Self-citationTough, D. F., & Sprent, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.3.357 · Cited by 98
The importance of gd T cells in the resolution of pathogen‐induced inflammatory immune responses
Carding, S. R., & Egan, P. J. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.917302.x · Cited by 92
Yin, Z., Zhang, D.-H., Welte, T., Bahtiyar, G., Jung, S. S., Liu, L., Fu, X.-Y., Ray, A., & Craft, J. E. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.3056 · Cited by 82
Self-citationHuber, S. A., Shi, C., & Budd, R. C. (2002) · Journal of Virology · doi:10.1128/jvi.76.13.6487-6494.2002 · Cited by 79
Moretto, M. M., Durell, B. G., Schwartzman, J. D., & Khan, I. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7389 · Cited by 54
The role of γδ T cells in the airways
Lahn, M. (2000) · Journal of Molecular Medicine · doi:10.1007/s001090000123 · Cited by 40
Therapeutic Activity of NK Cells against Tumors
Basse, P. H., Whiteside, T. L., Chambers, W. H., & Herberman, R. B. (2001) · International Reviews of Immunology · doi:10.3109/08830180109054416 · Cited by 29
NOMURA, Matsuzaki, TAKADA, HIROMATSU, NABESHIMA, Nakamura, Kishihara, & Nomoto (1998) · Immunology · doi:10.1046/j.1365-2567.1998.00593.x · Cited by 21
Kelly, K. A., O’Brien, R. L., & Born, W. K. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00233.x · Cited by 6
Cited by
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
Cytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1252 · Cited by 1,573
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Castro, F., Cardoso, A. P., Gonçalves, R. M., Serre, K., & Oliveira, M. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00847 · Cited by 1,224
Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
Cai, Y., Shen, X., Ding, C., Qi, C., Li, K., Li, X., Jala, V. R., Zhang, H.-G., Wang, T., Zheng, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.08.001 · Cited by 1,026
Metadata
- Authors
- Gao, Y., Yang, W., Pan, M., Scully, E., Girardi, M., Augenlicht, L. H., Craft, J., & Yin, Z.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-08-04
- Volume
- 198
- Issue
- 3
- Pages
- 433-442
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2136570726
- Cited by
- 453
- References
- 34
- FWCI
- 4.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.